Tracey Morton joins Ablatus as CFO

We are pleased to announce the appointment of Tracey Morton who is now CFO at Ablatus Therapeutics. Tracey is a Fellow of the Chartered Institute of Management Accountants and has a Masters Degree in Business Law. 

She brings a wealth of leadership experience in Life Science and FCMG sectors – her most recent roles include one as CFO for an Oxford University spin off Bio-tech diagnostics company, where as part of a successful team, she participated in a $60 Million fundraising project in both the US and UK. 

The Board are delighted to have someone of Tracey’s calibre join the company and believe the breadth and operational experience, across multiple functional responsibilities, will be a huge benefit to us at this exciting time.